{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:46:10Z","timestamp":1784263570827,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study evaluates an automated fluorescence resonant energy transfer (FRET)\u2013based ADAMTS13 activity assay on the Ceveron S100 instrument for the diagnosis of thrombotic thrombocytopenic purpura. It addresses the challenge of high background fluorescence (HBF), a known concern from our manual FRET assay, and proposes strategies to minimize erroneous results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared FRET-Ceveron results with FRET-Manual (n\u2005=\u2005100) and Technozym (Technoclone) enzyme-linked immunosorbent assay (ELISA) (n\u2005=\u200552) using retrospective and prospective patient samples collected throughout 2024, alongside proficiency samples and standards with assigned values (n\u2005=\u200524). We analyzed 7 spiked samples with HBF and 14 patient samples exhibiting HBF while exploring predilution methods. Over 200 FRET-Ceveron reactions were examined to identify abnormal patterns and establish thresholds for HBF interference.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The FRET-Ceveron assay demonstrated a strong correlation (r\u00b2\u2005&amp;gt;\u20050.97) with Technozym ELISA, FRET-Manual, and target results. It successfully detected critically low ADAMTS13 levels (&amp;lt;10%) across various sample types (n\u2005=\u200515). While HBF affected both FRET methods, FRET-Ceveron displayed greater tolerance to HBF. No significant difference was found in FRET-Ceveron result accuracy for initial carbon nanotubes (CNTs) up to 1100 (P\u2005=\u2005.39), but significant differences were observed when CNTs exceeded 1100 (P\u2005=\u2005.02). Predilution effectively reduced HBF (P\u2005&amp;lt;\u2005.05), validating the results confirmed by Technozym ELISA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The fully automated FRET-Ceveron assay is a rapid and accurate method for ADAMTS13 testing, and it is particularly effective when a normal reaction pattern is observed (initial CNTs\u2005\u22641000 with a good linearity in reaction tracing during 7- to 22-minute measurements). New sample collection is preferred in the presence of HBF, with predilution as a viable option.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf061","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:18:51Z","timestamp":1756217931000},"page":"545-558","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of a fully automated ADAMTS13 activity assay utilizing fluorescence resonance energy transfer with a practical approach to address high background fluorescence interference"],"prefix":"10.1093","volume":"164","author":[{"given":"Jing","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Special Coagulation, Stanford Health Care , Palo Alto, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu M","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Okwan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Zehnder","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2025100407165453800_CIT0001","first-page":"21","article-title":"Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc NY Pathol Soc."},{"key":"2025100407165453800_CIT0002","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood.V2.6.542.542","article-title":"Thrombotic thrombocytopenic purpura; hemorrhagic diathesis with generalized platelet thromboses","volume":"2","author":"Singer","year":"1947","journal-title":"Blood."},{"key":"2025100407165453800_CIT0003","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med."},{"key":"2025100407165453800_CIT0004","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood."},{"key":"2025100407165453800_CIT0005","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood."},{"key":"2025100407165453800_CIT0006","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0040-1708541","article-title":"Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults","volume":"46","author":"Blennerhassett","year":"2020","journal-title":"Semin Thromb Hemost."},{"key":"2025100407165453800_CIT0007","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM197806152982407","article-title":"Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia","volume":"298","author":"Upshaw","year":"1978","journal-title":"N Engl J Med."},{"key":"2025100407165453800_CIT0008","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med."},{"key":"2025100407165453800_CIT0009","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer."},{"key":"2025100407165453800_CIT0010","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost."},{"key":"2025100407165453800_CIT0011","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood."},{"key":"2025100407165453800_CIT0012","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","article-title":"ADAMTS-13 assays in thrombotic thrombocytopenic purpura","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost."},{"key":"2025100407165453800_CIT0013","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenia purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood."},{"key":"2025100407165453800_CIT0014","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med."},{"key":"2025100407165453800_CIT0015","doi-asserted-by":"publisher","first-page":"29428","DOI":"10.1074\/jbc.M505513200","article-title":"The proximal carboxyl terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor","volume":"280","author":"Ai","year":"2005","journal-title":"J Biol Chem."},{"key":"2025100407165453800_CIT0016","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion."},{"key":"2025100407165453800_CIT0017","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol."},{"key":"2025100407165453800_CIT0018","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1160\/TH13-08-0688","article-title":"FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients","volume":"112","author":"Mancini","year":"2014","journal-title":"Thromb Haemost."},{"key":"2025100407165453800_CIT0019","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1055\/s-0038-1641151","article-title":"Evaluation of the fully automated HemosIL Acustar ADAMTS13 activity assay","volume":"118","author":"Favresse","year":"2018","journal-title":"Thromb Haemost."},{"key":"2025100407165453800_CIT0020","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb Haemost."},{"key":"2025100407165453800_CIT0021","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s11239-020-02086-8","article-title":"Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study","volume":"50","author":"Stratmann","year":"2020","journal-title":"J Thromb Thrombolysis."},{"key":"2025100407165453800_CIT0022","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jth.15157","article-title":"A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity","volume":"19","author":"Favaloro","year":"2021","journal-title":"J Thromb Haemost."},{"key":"2025100407165453800_CIT0023","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.rpth.2023.100108","article-title":"ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura","volume":"7","author":"Singh","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"2025100407165453800_CIT0024"},{"key":"2025100407165453800_CIT0025","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/ajcp\/aqae160","article-title":"Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology,","volume":"163","author":"Jacobs","year":"2024","journal-title":"Am J Clin Pathol."},{"key":"2025100407165453800_CIT0026","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jphotochemrev.2013.10.005","article-title":"Carbon nanotube-based fluorescence sensors","volume":"19","author":"Li","year":"2014","journal-title":"J Photochem Photobiol C."},{"key":"2025100407165453800_CIT0027","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0032-1328972","article-title":"Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia","volume":"39","author":"Lippi","year":"2013","journal-title":"Semin Thromb Hemost."},{"key":"2025100407165453800_CIT0028","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jon.13149","article-title":"Differences in radiopacity among CT contrast agents and concentrations: a quantitative study","volume":"33","author":"Mehta","year":"2023","journal-title":"J Neuroimaging."},{"key":"2025100407165453800_CIT0029","author":"Harvard Medical School"},{"key":"2025100407165453800_CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-5067-2_2","article-title":"Digital radiography detectors: a technical overview","volume-title":"Digital Imaging Systems for Plain Radiography","author":"Lan\u00e7a","year":"2013"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/4\/545\/64138285\/aqaf061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/4\/545\/64138285\/aqaf061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:17:00Z","timestamp":1759576620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/4\/545\/8241367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf061","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,8,26]]}}}